 Hemolytic-uremic syndrome bone marrow transplantation adults hematologic malignancies adult patients B-cell non-Hodgkin lymphoma NHL hematologic malignancies autologous allogeneic bone marrow transplantation BMT subsequent development hemolytic-uremic syndrome HUS patients cyclophosphamide total body irradiation intervals first year post-BMT patients uniform measurements hematocrit Hct serum creatinine Sixteen patients Hct values normal range BMT populations sudden decrease Hct creatinine months post-BMT clinical laboratory criteria HUS None patients active cytomegalovirus infection graft-versus-host disease cyclosporine administration degree decrease Hct creatinine elevation laboratory abnormalities significant syndrome patients acute clinical complications congestive heart failure hypertension HTN peripheral edema patients red blood cell support patients platelet transfusions hemolytic anemia thrombocytopenia cases mean months postdiagnosis creatinine elevations HTN patients life-threatening long-term sequelae use BMT curative modality patients hematologic malignancies important patients development HUS potential long-term impact renal function